Last updated: 11/04/2018 13:43:41

Survey on the pharmacy follow-up of Alli purchasers

GSK study ID
W5350856
See study documents
Clinicaltrials.gov ID
NCT01387243
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Survey on the pharmacy follow up of Alli purchasers
Trial description: To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Change in Physical activity

Timeframe: baseline to 1 year

Secondary outcomes:

Change in dietary behavior

Timeframe: baseline to 1 year

Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)

Timeframe: baseline to 1 year

Satisfaction with management (i.e., results on weight and treatment comfort)

Timeframe: baseline to 1 year

Interventions:
  • Drug: Orlistat
    • Enrollment:
    80
    Primary completion date:
    2010-31-12
    Observational study model:
    Cohort
    Time perspective:
    Prospective
    Clinical publications:
    Not applicable
    Medical condition
    Overweight
    Product
    Not applicable
    Collaborators
    Not applicable
    Study date(s)
    January 2010 to December 2010
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Female & Male
    Age
    18+ years
    Accepts healthy volunteers
    No
    • Inclusion Criteria:
    • Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.
    Inclusion and exclusion criteria
    Inclusion criteria:
    • Inclusion Criteria:
    • Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.

    Trial location(s)

    This study does not involve prospective enrollment of participants.

    Study documents

    Scientific result summary
    Available language(s): English
    Download document(s)

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    2010-31-12
    Actual study completion date
    2010-31-12

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website